Cost-effectiveness of skin-barrier-enhancing emollients among preterm infants in Bangladesh

Amnesty E Lefevre, Samuel D. Shillcutt, Samir K. Saha, A. S M Nawshad Uddin Ahmed, Saifuddin Ahmed, M. A K Azad Chowdhury, Paul A. Law, Robert E Black, Mathuram Santosham, Gary L. Darmstadt

Research output: Contribution to journalArticle

Abstract

Objective: To evaluate the cost-effectiveness of topical emollients, sunflower seed oil (SSO) and synthetic Aquaphor, versus no treatment, in preventing mortality among hospitalized preterm infants (<33 weeks gestation) at a tertiary hospital in Bangladesh. Methods: Evidence from a randomized controlled efficacy trial was evaluated using standard Monte Carlo simulation. Programme costs were obtained from a retrospective review of activities. Patient costs were collected from patient records. Health outcomes were calculated as deaths averted and discounted years of life lost (YLLs) averted. Results were deemed cost-effective if they fell below a ceiling ratio based on the per capita gross national income of Bangladesh (United States dollars, US$ 470). Findings: Aquaphor and SSO were both highly cost-effective relative to control, reducing neonatal mortality by 26% and 32%, respectively. SSO cost US$ 61 per death averted and US$ 2.15 per YLL averted (I$ 6.39, international dollars, per YLL averted). Aquaphor cost US$ 162 per death averted and US$ 5.74 per YLL averted (I$ 17.09 per YLL averted). Results were robust to sensitivity analysis. Aquaphor was cost-effective relative to SSO with 77% certainty: it cost an incremental US$ 26 more per patient treated, but averted 1.25 YLLs (US$ 20.74 per YLL averted). Conclusion: Topical therapy with SSO or Aquaphor was highly cost-effective in reducing deaths from infection among the preterm neonates studied. The choice of emollient should be made taking into account budgetary limitations and ease of supply. Further research is warranted on additional locally available emollients, use of emollients in community-based settings and generalizability to other geographic regions.

Original languageEnglish (US)
Pages (from-to)104-112
Number of pages9
JournalBulletin of the World Health Organization
Volume88
Issue number2
DOIs
StatePublished - Feb 2010

Fingerprint

Emollients
Bangladesh
Premature Infants
Cost-Benefit Analysis
Costs and Cost Analysis
Skin
Infant Mortality
Tertiary Care Centers
Randomized Controlled Trials
sunflower seed oil
Newborn Infant

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Lefevre, A. E., Shillcutt, S. D., Saha, S. K., Nawshad Uddin Ahmed, A. S. M., Ahmed, S., Azad Chowdhury, M. A. K., ... Darmstadt, G. L. (2010). Cost-effectiveness of skin-barrier-enhancing emollients among preterm infants in Bangladesh. Bulletin of the World Health Organization, 88(2), 104-112. https://doi.org/10.2471/BLT.08.058230

Cost-effectiveness of skin-barrier-enhancing emollients among preterm infants in Bangladesh. / Lefevre, Amnesty E; Shillcutt, Samuel D.; Saha, Samir K.; Nawshad Uddin Ahmed, A. S M; Ahmed, Saifuddin; Azad Chowdhury, M. A K; Law, Paul A.; Black, Robert E; Santosham, Mathuram; Darmstadt, Gary L.

In: Bulletin of the World Health Organization, Vol. 88, No. 2, 02.2010, p. 104-112.

Research output: Contribution to journalArticle

Lefevre, AE, Shillcutt, SD, Saha, SK, Nawshad Uddin Ahmed, ASM, Ahmed, S, Azad Chowdhury, MAK, Law, PA, Black, RE, Santosham, M & Darmstadt, GL 2010, 'Cost-effectiveness of skin-barrier-enhancing emollients among preterm infants in Bangladesh', Bulletin of the World Health Organization, vol. 88, no. 2, pp. 104-112. https://doi.org/10.2471/BLT.08.058230
Lefevre, Amnesty E ; Shillcutt, Samuel D. ; Saha, Samir K. ; Nawshad Uddin Ahmed, A. S M ; Ahmed, Saifuddin ; Azad Chowdhury, M. A K ; Law, Paul A. ; Black, Robert E ; Santosham, Mathuram ; Darmstadt, Gary L. / Cost-effectiveness of skin-barrier-enhancing emollients among preterm infants in Bangladesh. In: Bulletin of the World Health Organization. 2010 ; Vol. 88, No. 2. pp. 104-112.
@article{542ae3adc85444afa6065b6afd46c4db,
title = "Cost-effectiveness of skin-barrier-enhancing emollients among preterm infants in Bangladesh",
abstract = "Objective: To evaluate the cost-effectiveness of topical emollients, sunflower seed oil (SSO) and synthetic Aquaphor, versus no treatment, in preventing mortality among hospitalized preterm infants (<33 weeks gestation) at a tertiary hospital in Bangladesh. Methods: Evidence from a randomized controlled efficacy trial was evaluated using standard Monte Carlo simulation. Programme costs were obtained from a retrospective review of activities. Patient costs were collected from patient records. Health outcomes were calculated as deaths averted and discounted years of life lost (YLLs) averted. Results were deemed cost-effective if they fell below a ceiling ratio based on the per capita gross national income of Bangladesh (United States dollars, US$ 470). Findings: Aquaphor and SSO were both highly cost-effective relative to control, reducing neonatal mortality by 26{\%} and 32{\%}, respectively. SSO cost US$ 61 per death averted and US$ 2.15 per YLL averted (I$ 6.39, international dollars, per YLL averted). Aquaphor cost US$ 162 per death averted and US$ 5.74 per YLL averted (I$ 17.09 per YLL averted). Results were robust to sensitivity analysis. Aquaphor was cost-effective relative to SSO with 77{\%} certainty: it cost an incremental US$ 26 more per patient treated, but averted 1.25 YLLs (US$ 20.74 per YLL averted). Conclusion: Topical therapy with SSO or Aquaphor was highly cost-effective in reducing deaths from infection among the preterm neonates studied. The choice of emollient should be made taking into account budgetary limitations and ease of supply. Further research is warranted on additional locally available emollients, use of emollients in community-based settings and generalizability to other geographic regions.",
author = "Lefevre, {Amnesty E} and Shillcutt, {Samuel D.} and Saha, {Samir K.} and {Nawshad Uddin Ahmed}, {A. S M} and Saifuddin Ahmed and {Azad Chowdhury}, {M. A K} and Law, {Paul A.} and Black, {Robert E} and Mathuram Santosham and Darmstadt, {Gary L.}",
year = "2010",
month = "2",
doi = "10.2471/BLT.08.058230",
language = "English (US)",
volume = "88",
pages = "104--112",
journal = "Bulletin of the World Health Organization",
issn = "0042-9686",
publisher = "World Health Organization",
number = "2",

}

TY - JOUR

T1 - Cost-effectiveness of skin-barrier-enhancing emollients among preterm infants in Bangladesh

AU - Lefevre, Amnesty E

AU - Shillcutt, Samuel D.

AU - Saha, Samir K.

AU - Nawshad Uddin Ahmed, A. S M

AU - Ahmed, Saifuddin

AU - Azad Chowdhury, M. A K

AU - Law, Paul A.

AU - Black, Robert E

AU - Santosham, Mathuram

AU - Darmstadt, Gary L.

PY - 2010/2

Y1 - 2010/2

N2 - Objective: To evaluate the cost-effectiveness of topical emollients, sunflower seed oil (SSO) and synthetic Aquaphor, versus no treatment, in preventing mortality among hospitalized preterm infants (<33 weeks gestation) at a tertiary hospital in Bangladesh. Methods: Evidence from a randomized controlled efficacy trial was evaluated using standard Monte Carlo simulation. Programme costs were obtained from a retrospective review of activities. Patient costs were collected from patient records. Health outcomes were calculated as deaths averted and discounted years of life lost (YLLs) averted. Results were deemed cost-effective if they fell below a ceiling ratio based on the per capita gross national income of Bangladesh (United States dollars, US$ 470). Findings: Aquaphor and SSO were both highly cost-effective relative to control, reducing neonatal mortality by 26% and 32%, respectively. SSO cost US$ 61 per death averted and US$ 2.15 per YLL averted (I$ 6.39, international dollars, per YLL averted). Aquaphor cost US$ 162 per death averted and US$ 5.74 per YLL averted (I$ 17.09 per YLL averted). Results were robust to sensitivity analysis. Aquaphor was cost-effective relative to SSO with 77% certainty: it cost an incremental US$ 26 more per patient treated, but averted 1.25 YLLs (US$ 20.74 per YLL averted). Conclusion: Topical therapy with SSO or Aquaphor was highly cost-effective in reducing deaths from infection among the preterm neonates studied. The choice of emollient should be made taking into account budgetary limitations and ease of supply. Further research is warranted on additional locally available emollients, use of emollients in community-based settings and generalizability to other geographic regions.

AB - Objective: To evaluate the cost-effectiveness of topical emollients, sunflower seed oil (SSO) and synthetic Aquaphor, versus no treatment, in preventing mortality among hospitalized preterm infants (<33 weeks gestation) at a tertiary hospital in Bangladesh. Methods: Evidence from a randomized controlled efficacy trial was evaluated using standard Monte Carlo simulation. Programme costs were obtained from a retrospective review of activities. Patient costs were collected from patient records. Health outcomes were calculated as deaths averted and discounted years of life lost (YLLs) averted. Results were deemed cost-effective if they fell below a ceiling ratio based on the per capita gross national income of Bangladesh (United States dollars, US$ 470). Findings: Aquaphor and SSO were both highly cost-effective relative to control, reducing neonatal mortality by 26% and 32%, respectively. SSO cost US$ 61 per death averted and US$ 2.15 per YLL averted (I$ 6.39, international dollars, per YLL averted). Aquaphor cost US$ 162 per death averted and US$ 5.74 per YLL averted (I$ 17.09 per YLL averted). Results were robust to sensitivity analysis. Aquaphor was cost-effective relative to SSO with 77% certainty: it cost an incremental US$ 26 more per patient treated, but averted 1.25 YLLs (US$ 20.74 per YLL averted). Conclusion: Topical therapy with SSO or Aquaphor was highly cost-effective in reducing deaths from infection among the preterm neonates studied. The choice of emollient should be made taking into account budgetary limitations and ease of supply. Further research is warranted on additional locally available emollients, use of emollients in community-based settings and generalizability to other geographic regions.

UR - http://www.scopus.com/inward/record.url?scp=75649119674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75649119674&partnerID=8YFLogxK

U2 - 10.2471/BLT.08.058230

DO - 10.2471/BLT.08.058230

M3 - Article

C2 - 20428367

AN - SCOPUS:75649119674

VL - 88

SP - 104

EP - 112

JO - Bulletin of the World Health Organization

JF - Bulletin of the World Health Organization

SN - 0042-9686

IS - 2

ER -